364 related articles for article (PubMed ID: 16581344)
1. Impact of native VLDL on tissue factor pathway inhibitor in endothelial cells and interactions between TFPI and lipoprotein lipase.
Brodin E; Iversen N; Hansen JB
J Lab Clin Med; 2006 Apr; 147(4):167-73. PubMed ID: 16581344
[TBL] [Abstract][Full Text] [Related]
2. Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro.
Hansen JB; Svensson B; Olsen R; Ezban M; Osterud B; Paulssen RH
Thromb Haemost; 2000 Jun; 83(6):937-43. PubMed ID: 10896252
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of lipoprotein lipase activity by tissue factor pathway inhibitor.
Mukherjee M; Kakkar VV
Thromb Haemost; 1999 Dec; 82(6):1648-51. PubMed ID: 10613650
[TBL] [Abstract][Full Text] [Related]
4. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of in vitro lipolysis of human very low-density lipoprotein by lipoprotein lipase.
Schreier L; Berg G; Zago V; Gonzalez AI; Wikinski R
Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):13-8. PubMed ID: 12125224
[TBL] [Abstract][Full Text] [Related]
6. Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells.
Xu Z; Maiti D; Kisiel W; Duh EJ
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2819-25. PubMed ID: 17023682
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo measurement of lipoprotein lipase-dependent very low density lipoprotein (VLDL)-triglyceride hydrolysis in human VLDL: an alternative to the postheparin assay of lipoprotein lipase activity?
Pruneta V; Autran D; Ponsin G; Marcais C; Duvillard L; Verges B; Berthezene F; Moulin P
J Clin Endocrinol Metab; 2001 Feb; 86(2):797-803. PubMed ID: 11158049
[TBL] [Abstract][Full Text] [Related]
8. Oxidized low-density lipoprotein impairs the anti-coagulant function of tissue-factor-pathway inhibitor through oxidative modification by its high association and accelerated degradation in cultured human endothelial cells.
Horie S; Hiraishi S; Hirata Y; Kazama M; Matsuda J
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):277-85. PubMed ID: 11085919
[TBL] [Abstract][Full Text] [Related]
9. Release of endothelial cell lipoprotein lipase by plasma lipoproteins and free fatty acids.
Saxena U; Witte LD; Goldberg IJ
J Biol Chem; 1989 Mar; 264(8):4349-55. PubMed ID: 2925647
[TBL] [Abstract][Full Text] [Related]
10. Relative quantification of glycosaminoglycan-induced upregulation of TFPI-mRNA expression in vitro.
Thyzel E; Kohli S; Siegling S; Prante C; Kleesiek K; Götting C
Thromb Res; 2007; 119(6):785-91. PubMed ID: 16919311
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein lipase facilitates very low density lipoprotein binding to the subendothelial cell matrix.
Saxena U; Ferguson E; Auerbach BJ; Bisgaier CL
Biochem Biophys Res Commun; 1993 Jul; 194(2):769-74. PubMed ID: 8343159
[TBL] [Abstract][Full Text] [Related]
12. Intravascular release and urinary excretion of tissue factor pathway inhibitor during heparin treatment.
Brodin E; Svensson B; Paulssen RH; Nordoy A; Hansen JB
J Lab Clin Med; 2004 Nov; 144(5):246-53; discussion 226-7. PubMed ID: 15570242
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidylcholine decreases the synthesis of tissue factor pathway inhibitor in human umbilical vein endothelial cells.
Sato N; Kokame K; Miyata T; Kato H
Thromb Haemost; 1998 Jan; 79(1):217-21. PubMed ID: 9459350
[TBL] [Abstract][Full Text] [Related]
14. Requirement for enzymatically active lipoprotein lipase in neuronal differentiation: a site-directed mutagenesis study.
Paradis E; Julien P; Ven Murthy MR
Brain Res Dev Brain Res; 2004 Mar; 149(1):29-37. PubMed ID: 15013626
[TBL] [Abstract][Full Text] [Related]
15. Melatonin stimulates release of tissue factor pathway inhibitor from the vascular endothelium.
Kostovski E; Dahm AE; Iversen N; Hjeltnes N; Østerud B; Sandset PM; Iversen PO
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):254-9. PubMed ID: 21297449
[TBL] [Abstract][Full Text] [Related]
16. [The great Scandinavian Medical Jahre Prize 1994. Role of lipoprotein lipase in lipoprotein metabolism].
Olivecrona T
Nord Med; 1995; 110(1):4-8. PubMed ID: 7831108
[TBL] [Abstract][Full Text] [Related]
17. Expression of the V264M TFPI mutant in endothelial cell cultures may involve mRNA stability.
Skretting G; Lien T; Sandset PM; Iversen N
Thromb Res; 2009 Apr; 123(6):851-5. PubMed ID: 19007969
[TBL] [Abstract][Full Text] [Related]
18. Evidence that the C-terminus of tissue factor pathway inhibitor (TFPI) is essential for its in vitro and in vivo interaction with lipoproteins.
Valentin S; Nordfang O; Bregengård C; Wildgoose P
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):713-20. PubMed ID: 8292720
[TBL] [Abstract][Full Text] [Related]
19. Effects of lipoproteins from pre-eclamptic women on umbilical endothelial cell 6-oxo-prostaglandin f1alpha and endothelin 1 synthesis, and nitric oxide synthase 3 mRNA expression.
Barden A; Beilin LJ; Both K; Ritchie J; Leedman P; Walters BN; Michael CA
Clin Sci (Lond); 1999 Dec; 97(6):697-706. PubMed ID: 10585897
[TBL] [Abstract][Full Text] [Related]
20. Oxidized low density lipoprotein inhibited tissue factor pathway inhibitor mRNA expression in human endothelial cells.
Wang G; Deng Z; Ni J
Chin Med J (Engl); 2000 Jul; 113(7):667-9. PubMed ID: 11776044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
